- Home
- ARWR vs QS Comparison
ARWR vs QS Comparison
Compare ARWR & QS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARWR | QS |
|---|---|---|
| Founded | 2003 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 7.5B |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARWR | QS |
|---|---|---|
| Price | $67.24 | $10.47 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 10 | 8 |
| Target Price | ★ $63.70 | $9.06 |
| AVG Volume (30 Days) | 2.6M | ★ 15.3M |
| Earning Date | 02-09-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $829,448,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 23258.15 | N/A |
| 52 Week Low | $9.57 | $3.40 |
| 52 Week High | $72.36 | $19.07 |
Technical Indicators
Market Signals| Indicator | ARWR | QS |
|---|---|---|
| Relative Strength Index (RSI) | 61.61 | 35.04 |
| Support Level | $68.00 | $11.09 |
| Resistance Level | $71.30 | $11.80 |
| Average True Range (ATR) | 3.40 | 0.65 |
| MACD | -0.86 | -0.02 |
| Stochastic Oscillator | 60.00 | 1.03 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About QS QuantumScape Corporation
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles and other applications. The company's solid-state lithium-metal battery technology is designed to offer greater energy density, faster charging, and enhanced safety. Its battery cells have none of the host materials used in conventional anodes.